Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.95 |
| ▸ | LMNA | P02545 | 1/20 | 0.95 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Orotic Acid SCHEMBL231368 | 1.00 | ALDH1A1 (0.95) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL23859825 | 1.00 | ALDH1A1 (0.95) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL28141346 | 0.98 | ALDH1A1 (0.91) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL20865 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL431534 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL29394966 | 0.98 | ALDH1A1 (1.00) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL422602 | 0.95 | ALDH1A1 (0.95) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL896844 | 0.95 | ALDH1A1 (0.95) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL122311 | 0.95 | ALDH1A1 (0.95) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 | |
| Orotic Acid SCHEMBL2293911 | 0.95 | ALDH1A1 (0.95) | ALDH1A1LMNACYP2C19CYP1A2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4418865-B1 | LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX | LIPOID GMBH (DE) | 2025-12-10 | — | — | EP | claimed |
| EP-4225318-B1 | MAGNESIUM OROTATE IN COMBINATION WITH FOLIC ACID FOR THE TREATMENT OF DEMENTIA | WOERWAG PHARMA GMBH & CO KG (DE) | 2024-11-13 | — | — | EP | claimed |
| EP-4432857-A1 | COMPOSITION FOR PROTECTING THE EYE | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH (DE) | 2024-09-25 | — | — | EP | claimed |
| EP-3359138-B1 | DIETARY SUPPLEMENTATION TO ACHIEVE OXY-REDOX HOMEOSTASIS AND EPIGENETIC STABILITY | PARTHENOGEN SAGL (CH) | 2024-04-24 | — | — | EP | claimed |
| WO-2023186536-A1 | COMPOSITION FOR PROTECTING THE EYE | MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBH (DE) | 2023-10-05 | — | — | WO | claimed |
| EP-4225318-A1 | BIOFACTORS FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA | WÖRWAG Pharma GmbH & Co.KG (DE) | 2023-08-16 | — | — | EP | claimed |
| EP-3212191-B1 | TREATMENT FOR DEPRESSION AND DEPRESSIVE DISORDERS | MEDLAB IP PTY LTD (AU) | 2022-10-05 | — | — | EP | claimed |
| WO-2022074114-A1 | BIOFACTORS FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA | Wörwag Pharma GmbH & Co.KG (DE) | 2022-04-14 | — | — | WO | claimed |
| EP-3981407-A1 | BIOFACTORS FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA | WÖRWAG Pharma GmbH & Co.KG (DE) | 2022-04-13 | — | — | EP | claimed |
| EP-4225318-B1 | MAGNESIUM OROTATE IN COMBINATION WITH FOLIC ACID FOR THE TREATMENT OF DEMENTIA | WOERWAG PHARMA GMBH & CO KG (DE) | 2024-11-13 | — | — | EP | disclosed |
| EP-4432857-A1 | COMPOSITION FOR PROTECTING THE EYE | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH (DE) | 2024-09-25 | — | — | EP | disclosed |
| WO-2023186536-A1 | COMPOSITION FOR PROTECTING THE EYE | MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBH (DE) | 2023-10-05 | — | — | WO | disclosed |
| EP-4225318-A1 | BIOFACTORS FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA | WÖRWAG Pharma GmbH & Co.KG (DE) | 2023-08-16 | — | — | EP | disclosed |
| EP-4147691-A1 | COMPOSITION AND ADMINISTRATION FORM COMPRISING FIRST AND SECOND FUCOIDAN | Lighthouse Pharma GmbH (DE) | 2023-03-15 | — | — | EP | disclosed |
| WO-2022074114-A1 | BIOFACTORS FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA | Wörwag Pharma GmbH & Co.KG (DE) | 2022-04-14 | — | — | WO | disclosed |
| EP-3981407-A1 | BIOFACTORS FOR THE TREATMENT AND PROPHYLAXIS OF DEMENTIA | WÖRWAG Pharma GmbH & Co.KG (DE) | 2022-04-13 | — | — | EP | disclosed |